Patients treated for cholesterol lowering appear to have extra benefits.
Read More »40% of Diabetes Patients Not Getting Treatment To Prevent Heart Attacks and Strokes
Research reveals important gaps in care.
Read More »A New Way to Look at Diabetes: Exclusive Interview with Anthony Cincotta, Part 2
In part 2 of this exclusive ADA interview, Anthony Cincotta discusses the Cycloset Safety Trial study design and findings regarding the cardiovascular safety of Cycloset.
Read More »The Science of Cycloset: Exclusive Interview with Anthony Cincotta, Part 1
In part 1 of this exclusive ADA interview, Anthony Cincotta discusses the mechanistic science behind the development of Cycloset, and why preclinical and clinical findings suggest the therapy may reset clock mechanisms governing postprandial glucose metabolism.
Read More »Pioglitazone First Medication to Prevent Diabetes Progression Including Cardiovascular Events
Study could not evaluate drug's long-term effects on diabetes prevention, length of effects
Read More »Cardiovascular Mortality of Diabetes Medications
What should be the proper treatment selection for patients with type 2 diabetes?
Read More »Metformin in Type 1 Patients Slows Development of Heart Disease
Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.
Read More »LDL-C Levels and Cardiovascular Risk
What is the best strategy to target LDL-C levels and improve cardiovascular outcomes?
Read More »Liraglutide Use in Heart Failure Patients
Cardioprotective effects of the drug are focus of research.
Read More »Uncovering the Cardiovascular Effects of Pioglitazone
Is pioglitazone a viable option for patients with insulin resistance and recent stroke or myocardial infarction?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.